ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
This field is for validation purposes and should be left unchanged.

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
This field is for validation purposes and should be left unchanged.
go to the article

go back to the homepage

  • BIOCOM CARD
  • Newsletter
  • Advertising
  • Job Market
  • Shop
European Biotechnology Magazine
biocom_logo
  • Latest news
  • Background
  • Opinion
  • The Mag
    • Issues
    • Special
    • Subscribe
  • Euro Biotech Guide
  • Market Place
    • Products
    • Sponsored Publications
    • Advertise
  • Associations
  • Service
    • Job Market
    • Newsletter
    • Contact Us
    • Editorial Team
  • Events
  • Search
  • Menu Menu

ADVERTISEMENT

Norwegian Actithera adds the covalent bond to the target to the RLT space (left side) which leads to a improved retention time at the tumor with minimal background over several daysActithera Norway AS
Radiopharmaceuticals

Actithera: Radiopharma Funding Gathers Hug...

The biotech company Actithera, with locations in Cambridge, USA, and Oslo, Norway, has successfully closed a major Series A round, raising US $75.5 million. Its isotope-agnostic platform — designed … more ➔

Cellular exosomes are small extracellular vesicles that target specific organs or molecular addresses in the body.adobe stock photos - Wang Dan
Adipositas

Ciloa SAS secures €6.5m to advance lead...

French biotech Ciloa SAS has received a €6.5m grant to advance its adiponectin-loaded exosome candidate, APN-sEV, into Phase I safety trials, ahead of efficacy evaluation in indications including type … more ➔

ADVERTISEMENT

Solarfoods2Solar Foods
Food Biotechnology

Solar Foods continues expansion in the US

After Finnish protein powder producer Solarfoods signed a strategic agreement with two US food manufacturers to supply 6,000 tonnes of Solein from 2030 onwards, the company has now announced a more concrete … more ➔

Executive Vice-Presidents Stéphane Séjourné (right) and Research Commissioner Ekaterina Zaharieva (middle) at the presentation of the EU Life Sciences StrategyEC
European Commission

European Commission to fund Life Sciences...

The European Commission last week unveiled its Life Sciences Strategy, which aims to elevate Europe’s biotechnology sector from third to first place globally by 2030, backed by an investment of €10bn. … more ➔

Sandoz' biosimilars production facility in  Brnik is expected to start operations in 2028.Sandoz
Biomanufacturing

Sandoz breaks ground on US$440m biosimilar...

Biosimilar major Sandoz has started construction of an additional US$440m biosimilar facility near Ljubljana and it set to expand its investment footprint in Slovenia by US$1.1bn. more ➔

European Biotechnology

1 / 4
01_EB225_Titel.indd

This issue focuses on the art of upscaling industrial biotechnology in Europe, the impact of the Trump factor on the life sciences and the European Commission's new billion-euro fund for emerging … more ➔

Get a free sample copy | Abo
2 / 4
EB125_Cover

This issue offers insights into Europe's fight for green solutions for a bioeconomy, antimicrobial resistance and how Europe is preparing for the next pandemic. more ➔

Get a free sample copy | Abo
3 / 4
EB424_Cover

Since the first antibody drug was approved back in 1986, monoclonal antibodies have emerged as the dominant class in the global US$417bn market for biologics. At the end of 2023, sales stood at more … more ➔

Get a free sample copy | Abo
4 / 4
EB324_Titel

The first half of 2024 is history, and experts are divided on whether the financing nadir has been reached or even passed. There are very different figures for different types of treatments under … more ➔

Get a free sample copy | Abo
❮❯

ADVERTISEMENT

© AI
european-biotechnology-logo

NEWSLETTER


Stay up to date with the biotech industry!

Once a week, european-biotechnology.com brings you up to date on the latest developments in the biotech industry. In our free newsletter, you will find the latest news from business, research and politics, as well as lots of useful information and job vacancies.


Subscribe to our free newsletter!Subscribe here

Syntethic macrocyclic peptid compared with a typical small molecule drugUnnatural Products Inc
Partnership

Argenx and Unnatural Products ink US$1.5bn...

California oral macrocyclic peptide specialist Unnatural Products, Inc. and Dutch-Belgian Argenx SE have formed a multi-target research collaboration aimed at developing oral macrocyclic peptide drugs … more ➔

Vetter marks the start of new clinical site construction with groundbreaking ceremony. Participants from left to right: Tom Kikta, Wolfgang Kerkhoff, Gunther Strothe, Dr. Susanne Lemaine, Senator h.c. Udo J. Vetter, Andrew Goczkowski, Thomas Otto, Thomas Ruebekeil, Henryk Badack, RT Evans.Vetter Pharma International GmbH
CDMO

Vetter invests US$285m in Chicago producti...

CDMO and filled syringe specialist Vetter has broken the ground for a new clinical site construction in the greater Chicago area that is expected to be ready for early clinical filling by the end of … more ➔

ADVERTISEMENT

Sponsored Publications

1 / 2
product_02_bg[63]
Meteor Biotech

Unlocking the Future of Precision Biology with Spatial Cell Sorting

Spatial precision in cell analysis is revolutionizing biomedical research. SLACS (Spatially-resolved Laser Activated Cell Sorting) uniquely isolates live microniches within tissues, preserving spatial … more ➔

2 / 2
Monarch_Advertorial_202502_EU
New England Biolabs

The Bridge to your success

Customized Enzymes and Reagents from New England Biolabs. Creating the right partnership is essential when pioneering a new life science product. more ➔

APPOINTMENTS

all appointments

EB.com_Claus_Engstrand_klEnzymatica AB
Enzymatica AB

Enzymatica CEO steps down

The CEO of Lund-based Enzymatica AB, Claus Egstrand, is stepping down from his role. CFO Therese Filmersson will also leave her position. …
more ➔

EB.com_Trine_Ahlgreen_MC2_TherapeuticsMC2 Therapeutics A/S
MC2 Therapeutics A/S

New CEO – new chapter

MC2 Therapeutics A/S, a Hørsholm-based pharmaceutical company focused on topical therapies in inflammatory skin conditions, announced …
more ➔

EB.com_Dieter_Weinand_mak_klSibylla Biotech
Sibylla Biotech

Industry veteran appointed

Italian Sibylla Biotech has appointed a new Chairman of the Board of Directors: Dieter Weinand, former President, CEO and Chairman …
more ➔

tk.de_Regina_HoditsAngeline Ventures
Angelini Ventures

Reinforcement for Angelini Ventures

Dr Regina Hodits joined Angelini Ventures, the VC arm of Angelini Industries, in April as the new Managing Director. She will be based …
more ➔

Since 2022, AeoniQ uses ACIRCULOSE® pulp supplied by Renewcell to produce its sustainable fibresHeiQ/AeoniQ, Renewcell
bioeconomy

Altri acquires majority stake in fibre spe...

Portuguese fibre producer Altri SGPS S.A.has signed an agreement to acquire a majority interest in Swiss clean technology company AeoniQ to support the commercial-scale development of the first fully … more ➔

ADVERTISEMENT

Berlaymont building in Brusselsadobe stock photos - Sergii Figurnyi
NGT

Parliament halts trilogue talks on New Gen...

Final negotiations on proposed EU regulations for plants developed through genetic precision breeding have been delayed, following opposition from a group of MEPs in the European Parliament’s ENVI … more ➔

LaverockLaverock Therapeutics
Financing

Laverock Therapeutics bags additional £6....

British targeted gene silencing specialist Laverock Therapeutics Ltd has expanded its seed funding to £20m by a new financing round led by xx and xx. The company said it will use the funds to…l more ➔

All news
newsletter_link

EVENT


RMC2025nova-Institut GmbH
September 22 - September 24in Maternushaus

Renewable Materials Conference to be held in autumn

The international meeting place for the chemical, the plastics and materials industries will take place from 22 to 24 September 2025 in Siegburg/Cologne. It presents solutions and innovations for replacing fossil carbon with biomass, captured CO₂ and via recycling. ➔

© BIOCOM Interrelations GmbH
  • LinkedIn
  • Instagram
  • Contact
  • Imprint
  • Privacy policy
Scroll to top